HA
RPTP

Havens Advisors’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Havens Advisors’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-110,000
Closed -$987K – 55
2016
Q3 		$987K Buy
+110,000
New +$782K 0.77% 29

Havens Advisors's RPTP Position: Q4 2016 in Review

Havens Advisors sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 110,000 shares — an estimated $987K sold.

Havens Advisors first reported a position in RPTP in Q3 2016 and held it in 1 quarter. The position peaked at $987K in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Havens Advisors reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Havens Advisors sold 110,000 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $987K.
  • Havens Advisors first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2016 and held it in 1 quarter.
  • Havens Advisors's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $987K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Havens Advisors's 13F filing for Q4 2016, filed 10 Jan 2017.